搜尋結果
幣549.15 億元，同比增長 82.64%，國產影片年度票房人民幣 460.05 億元，創歷史新 高；其中，2023 年春節檔票房人民幣 67.58 億元，居歷史第二，暑期檔刷新了大盤 單日票房連續破億紀錄，並以人民幣 206.19 億元票房的成績創下檔期歷史新高。
5 天前 · Release Time: 02/12/2022 17:09 Stock Code: 02799 Stock Short Name: CHINA HUARONG Document: Monthly Returns Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2022 (63KB) Release Time: 24/11 ...
- Gross profit
- Loss before taxation
- Attributable to:
- Non-current assets
- Current assets
- (a) Statement of compliance
- 3. REVENUE
- 5. LOSS BEFORE TAXATION
- Current tax – PRC Corporate Income Tax
- Deferred tax
- 9. SEGMENT REPORTING
- (a) Segment results, assets and liabilities
- Loss
- Assets
- 10. TRADE AND OTHER RECEIVABLES
- 13. BANK AND OTHER BORROWINGS
- Current
- OUTLOOK
- As at 31 December 2020 2019
- Treasury Policies
- Interest Rate Exposure
- Basis of opinion
- Chairman
Other revenue and other income Other net loss Share of profit/(loss) of an associate Reversal of impairment loss/(impairment loss) of property, plant and equipment Reversal of impairment loss/(impairment loss) of trade receivables, net Impairment loss of other receivables, net Fair value change on financial liabilities at fair value through profit...
Income tax credit/(expense) Loss for the year from continuing operations Loss for the year from discontinued operation Loss for the year
Equity holders of the Company Non-controlling interests
Property, plant and equipment Intangible assets Goodwill Interest in an associate, net Prepayment for acquisition of an intangible asset Financial asset at fair value through profit or loss
Inventories Trade and other receivables Time deposits Pledged bank deposits Cash and cash equivalents Assets of a disposal group classified as held for sale/assets classified as held for sale
These financial statements have been prepared in accordance with all applicable Hong Kong Financial Reporting Standards (“HKFRSs”), which collective term includes all applicable individual Hong Kong Financial Reporting Standards, Hong Kong Accounting Standards (“HKASs”) and Interpretations issued by the Hong Kong Institute of Certified Public Accou...
The principal activities of the Group are research and development, manufacturing, sales and distribution of pharmaceutical products. The amount of each significant category of revenue is as follows:
Loss before taxation is arrived at after charging: Continuing operations
Provision for the year Over provision in respect of prior years
Origination and reversal of temporary differences Income tax (credit)/expense
The Group manages its businesses by business lines. In a manner consistent with the way in which information is reported internally to the Group’s most senior executive management for the purposes of resource allocation and performance assessment, the Group has presented the following one reportable segment: – Proprietary products production and sa...
For the purposes of assessing segment performance and allocation resources between segments, the Group’s most senior executive management, who are also the executive directors of the Company, monitors the results, assets and liabilities attributable to each reportable segment on the following bases: Segment assets include all tangible and intangibl...
Reportable segment operating loss Unallocated head office and corporate expenses Other revenue – unallocated Other net loss – unallocated Fair value change on financial liabilities at fair value through profit or loss Finance costs Consolidated loss before taxation (continuing operations)
Reportable segment assets Assets of a disposal group classified as held for sale Assets classified as held for sale Assets relating to discontinued operation Unallocated head office and corporate assets Consolidated total assets
Trade debtors and bills receivable Less: Loss allowance (note (b)) Deposits, prepayments and other receivables (note (c)) Continuing operations
Details of bank and other borrowings are as follows:
Secured bank borrowings Unsecured bank borrowings Secured other borrowings Unsecured other borrowings Other borrowings Corporate bonds
In the face of the global economic slowdown and domestic headwinds, the Chinese government has introduced strong fiscal and monetary policies to support businesses, stimulate domestic demand and maintain employment in order to tide over the difficult times. Although China’s growth rate is slowing down, the government is expected to continue to inv...
Loss attributable to equity shareholders of the Company
The primary objective of the Group’s capital management is to maintain its ability to continue as a going concern so that the Group can constantly provide returns for shareholders of the Company and benefits for other stakeholders by implementing proper product pricing and securing access to financing at reasonable costs. The Group actively and reg...
The Group’s interest rate risk arises primarily from bank loans, unsecured debenture and bank balances. Borrowings at variable rates expose the Group to cash flow interest rate risk. Currently, the Group does not employ any financial instruments to hedge against interest rate risk.
We conducted our audit in accordance with Hong Kong Standards on Auditing issued by the HKICPA. Our responsibilities under those standards are further described in the Auditor’s responsibilities for the audit of the consolidated financial statements section of our report. We are independent of the Group in accordance with the HKICPA’s Code of Ethic...
As at the date of this announcement, the executive Directors are Mr. Ng Tit, Ms. Chin Yu and Mr. Wu Weizhong; the non-executive Director is Dr. Qian Wei; and the independent non-executive Directors are Mr. Tze Shan Hailson Yu, Mr. Pan Fei and Dr. Zhao Yubiao.
HKEX :: HKEXnews
Net finance cost 12 (279,589) (163,922) Share of profits of associates 5 426,300 465,626 Profit before income tax 290,032 324,852 Income tax expense 13 (5,182) (7,270) Profit for the year 284,850 317,582 Other comprehensive income Item that may be/has
31 December 2021. 1. GENERAL INFORMATION. CSOP ETF Series OFC (the “Company”) is a public umbrella open-ended fund company with variable capital with limited liability, which was incorporated in Hong Kong under the Securities and Futures Ordinance (Cap. 571) of Hong Kong (the “SFO”) on 28 January 2021.
the People’s Republic of China 29,089 5,573 23,516 (xii) – Exchange difference reclassified to profit or loss upon disposal of a subsidiary – – – Item that will not be reclassified to profit or loss: – Revaluation surplus on leasehold land and buildings, net of tax
